Hong Kong

  • Funded by Coalition for Epidemic Preparedness Innovations (CEPI)
  • Total publications:1000 publications

Grant number: N/A

Grant search

Key facts

  • Disease

    COVID-19
  • start year

    2020
  • Known Financial Commitments (USD)

    $620,000
  • Funder

    Coalition for Epidemic Preparedness Innovations (CEPI)
  • Principle Investigator

    Pending
  • Research Location

    China, Western Pacific
  • Lead Research Institution

    Hong Kong University
  • Research Category

    Vaccines research, development and implementation

  • Research Subcategory

    Pre-clinical studies

  • Special Interest Tags

    Gender

  • Study Subject

    Non-Clinical

  • Clinical Trial Details

    N/A

  • Broad Policy Alignment

    Pending

  • Age Group

    Not Applicable

  • Vulnerable Population

    Not applicable

  • Occupations of Interest

    Not applicable

Abstract

Viral Vector / Nasal Flu construct with NS1 deletion. Includes the Receptor Binding Domain (RBD) of Covid-19 Preclinical proof of concept

Publicationslinked via Europe PMC

Last Updated:41 minutes ago

View all publications at Europe PMC

Two structurally new Lindqvist hexaniobate-templated silver thiolate clusters.

Clinical features of patients with mutations in genes for nanophthalmos.

Progranulin AAV gene therapy for frontotemporal dementia: translational studies and phase 1/2 trial interim results.

Impact of previous treatment history and B-cell depletion treatment duration on infection risk in relapsing-remitting multiple sclerosis: a nationwide cohort study.

Role of NaV1.7 in postganglionic sympathetic nerve function in human and guinea-pig arteries.

Gut-Directed Hypnotherapy May Pose Specific Challenges in Gender-Diverse Patients: A Review of 3 Patients.

Cost-effectiveness analysis of CYP3A5 genotype-guided tacrolimus dosing in solid organ transplantation using real-world data.

Misregulation of bromotyrosine compromises fertility in male Drosophila.

PSCK9 inhibitors reduced early recurrent stroke in patients with symptomatic intracranial atherosclerotic stenosis.